Visa (V) Tops Q2 EPS by 11c
Tweet
Share
E-mailGet Alerts V Hot Sheet
Price: $360.33 +0.25%
Financial Fact:
Diluted weighted-average shares outstanding (Note 8): -38M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Diluted weighted-average shares outstanding (Note 8): -38M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Visa (NYSE: V) reported Q2 EPS of $1.92, $0.11 better than the analyst estimate of $1.81. Revenue for the quarter came in at $3 billion versus the consensus estimate of $2.85 billion.
Payments volume growth, on a constant dollar basis, for the three months December 31, 2012, on which fiscal second quarter service revenue is recognized, was 9% over the prior year at $1.1 trillion.
Payments volume growth, on a constant dollar basis, for the three months ended March 31, 2013, was 9% over the prior year at $1.0 trillion.
Cross-border volume growth, on a constant dollar basis, was 10% for the three months ended March 31, 2013.
Total processed transactions, which represent transactions processed by VisaNet, for the three months ended March 31, 2013, were 13.9 billion, a 6% increase over the prior year.
For earnings history and earnings-related data on Visa (V) click here.
Payments volume growth, on a constant dollar basis, for the three months December 31, 2012, on which fiscal second quarter service revenue is recognized, was 9% over the prior year at $1.1 trillion.
Payments volume growth, on a constant dollar basis, for the three months ended March 31, 2013, was 9% over the prior year at $1.0 trillion.
Cross-border volume growth, on a constant dollar basis, was 10% for the three months ended March 31, 2013.
Total processed transactions, which represent transactions processed by VisaNet, for the three months ended March 31, 2013, were 13.9 billion, a 6% increase over the prior year.
For earnings history and earnings-related data on Visa (V) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ackman adds Netflix, Visa and Mastercard in portfolio revamp
- Omega Flex (OFLX) Tops Q2 EPS by 27c
- Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
Create E-mail Alert Related Categories
Earnings, Hot Earnings, Hot ListRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
